Bristol Myers Squibb Co. (BMY), And Talk Of Dividend Yields In Pharma

Page 1 of 2

As the market continues to climb, investors are beginning to see thinning dividend yields on many of their big pharma shares. But by sticking with quality – and with companies that are keeping their product pipelines full with new drugs – one can certainly find the key to not just share growth but also a nice steady income along the way.

Keeping yields healthy

Bristol Myers Squibb Co. (NYSE:BMY)One of the higher yielding big pharmaceutical companies, GlaxoSmithKline plc (ADR) (NYSE:GSK), operates through three primary segments: consumer health care, vaccines, and pharmaceuticals. This UK-based powerhouse has continued to expand into emerging markets – especially capitalizing on the growth that is taking place in many developing-international economies – which is a likely factor in its positive financials.

One of the biggest focus areas for GlaxoSmithKline plc (ADR) (NYSE:GSK) has been with its GLP-1 agonists. This medication for patients who are suffering from diabetes claims to offer less risk to its users than some of the other related types of medication that are currently available on the market today. GlaxoSmithKline plc (ADR) (NYSE:GSK) has also recently gained acceptance by the U.S. FDA for its fluticasone furoate, a COPD, or Chronic Obstructive Pulmonary Disease-management drug application.

Although analysts expect GlaxoSmithKline plc (ADR) (NYSE:GSK)’s share price to rise by only 3% over the next 12 months, the $2.76 per share dividend payout is yielding investors approximately 6% annually.

In keeping with healthy dividend yields, investors may also want to consider Eli Lilly & Co. (NYSE:LLY). Here, too, is a big pharma company that focuses on the development, manufacturing, and sale of drugs for both humans and animals. The span of Eli Lilly & Co. (NYSE:LLY)’s market encompasses the U.S. and roughly 130 additional countries.

This company also has a strong presence in the diabetes-management area with its investigational med Dulaglutide. Other medications that Eli Lilly & Co. (NYSE:LLY) currently has in clinical testing include a depression drug called Edivoxetine and a new insulin glargine product.

Eli Lilly & Co. (NYSE:LLY)’s recent announcement about an agreement it has entered into with Qiagen has been well received in the industry and by investors. This program will work in the area of development and commercialization of companion diagnostics with drugs across numerous therapeutic areas using both investigational meds and those that have already been approved for use.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Lists

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

12 Most Expensive Countries for Foreign Students

Top 30 Most Influential Women in the World

Top 20 Most Expensive New Year Eve Shows

Top 5 Best Vocational Careers

Top 10 Jobs for 2014 by Salary Gain (Predictions)

Top 5 Digital Trends for 2014

Top 6 Things You Can Do To Increase Your Productivity

Top 9 Trending Smartphones in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!